TGFB1 and Hepatic fibrosis: Current evidence suggests that FGFR2 may be a promising target [25,26,27], but more research is needed to determine the efficacy of FGFR2 as a target for liver fibrosis treatment as well as to fully understand the mechanisms behind its involvement in TGF-β signaling.